JP JAZZ PHARMACEUTICALS
Live / Registered — Registered (as of 04 Feb 2025)
What this means for you
Registered since 04 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98726519
- Registration number
- 7680334
- Mark type
- Design + words
- Filed
- 30 Aug 2024
- Published for opposition
- 17 Dec 2024
- Registered
- 04 Feb 2025
- Attorney of record
- Michael T. Olsen
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for the treatment and prevention of cancer, psychiatric diseases and disorders, central nervous system conditions, pain, sleep disorders, narcolepsy, schizophrenia, and for use in oncology and hematology; pharmaceutical products for the prevention and treatment of cancer; pharmaceutical preparations and substances for the treatment of psychiatric diseases and disorders; pharmaceutical preparations acting on the central nervous system; pain relief medication; pharmaceutical preparations for use in the treatment and/or management of sleep disorders; pharmaceutical preparations for the treatment of narcolepsy; pharmaceutical preparations for the treatment of schizophrenia; pharmaceutical preparations for use in oncology and hematology
Owner
- Jazz Pharmaceuticals Ireland Limited, Dublin, IE
- Jazz Pharmaceuticals Ireland Limited, Dublin, IE
- Jazz Pharmaceuticals Ireland Limited, Dublin, IE
Prior registrations
Prosecution history
- 21 Aug 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 04 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 04 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Nov 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Nov 2024 — EXAMINER'S AMENDMENT ENTERED
- 22 Nov 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Nov 2024 — EXAMINERS AMENDMENT E-MAILED
- 22 Nov 2024 — EXAMINERS AMENDMENT -WRITTEN
- 19 Nov 2024 — ASSIGNED TO EXAMINER
- 10 Nov 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 10 Nov 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Aug 2024 — NEW APPLICATION ENTERED